Immunotherapy of colorectal cancer.
Over the last decade, there has been a rapid expansion in the field of tumour immunology. There is now convincing evidence that both the cellular and humoral arms of the immune system are capable of interacting with tumour cells. The most significant advances have been in our understanding of cellul...
Main Authors: | Smith, C, Dulphy, N, Salio, M, Cerundolo, V |
---|---|
Format: | Journal article |
Language: | English |
Published: |
2002
|
Similar Items
-
Valpha24-JalphaQ-independent, CD1d-restricted recognition of alpha-galactosylceramide by human CD4(+) and CD8alphabeta(+) T lymphocytes.
by: Gadola, S, et al.
Published: (2002) -
Harnessing the power of invariant natural killer T cells in cancer immunotherapy
by: Bedard, M, et al.
Published: (2017) -
Immunotherapy of melanoma.
by: Smith, C, et al.
Published: (2001) -
Generation of CD1 tetramers as a tool to monitor glycolipid-specific T cells.
by: Gadola, S, et al.
Published: (2003) -
Efficient priming of antigen-specific cytotoxic T lymphocytes by human cord blood dendritic cells.
by: Salio, M, et al.
Published: (2003)